HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xavier Montalban Selected Research

Oligoclonal Bands

11/2022The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
1/2020New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
1/2018Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
1/2018The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
1/2018Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
1/2016Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
7/2015Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
4/2015Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
3/2015Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
5/2013CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: No.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xavier Montalban Research Topics

Disease

193Multiple Sclerosis
11/2022 - 02/2002
37Relapsing-Remitting Multiple Sclerosis
04/2022 - 10/2002
18Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 09/2002
12Autoimmune Diseases (Autoimmune Disease)
01/2022 - 09/2008
12Chronic Progressive Multiple Sclerosis
10/2021 - 06/2004
11Disease Progression
11/2021 - 09/2002
10Progressive Multifocal Leukoencephalopathy
01/2021 - 02/2012
9Demyelinating Diseases (Demyelinating Disease)
01/2022 - 05/2011
9Infections
12/2020 - 02/2010
9Atrophy
08/2020 - 11/2011
8Inflammation (Inflammations)
01/2022 - 01/2005
6Nervous System Diseases (Neurological Disorders)
01/2021 - 11/2014
6Neoplasms (Cancer)
01/2020 - 09/2008
5COVID-19
06/2022 - 07/2020
5Neuromyelitis Optica (Devic's Disease)
01/2017 - 05/2013
4Atrioventricular Block
11/2019 - 02/2010
3Stroke (Strokes)
12/2021 - 01/2020
3Macular Edema
06/2021 - 02/2010
3Fatigue
01/2021 - 08/2006
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 09/2012
3Neuroinflammatory Diseases
01/2020 - 01/2017
3Opportunistic Infections (Opportunistic Infection)
11/2019 - 03/2015
3Herpes Zoster
04/2019 - 02/2010
3Lymphopenia (Lymphocytopenia)
04/2019 - 03/2016
3Bradycardia
03/2016 - 02/2010
2Epilepsy (Aura)
12/2021 - 01/2021
2Parkinson Disease (Parkinson's Disease)
01/2021 - 07/2012
2Ulcerative Colitis
10/2020 - 07/2016
2Optic Neuritis (Retrobulbar Neuritis)
01/2020 - 04/2015
2Chickenpox
01/2018 - 02/2010
2Urinary Tract Infections (Urinary Tract Infection)
07/2016 - 02/2012

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
04/2022 - 08/2006
25Interferon-betaIBA
01/2019 - 09/2002
22Natalizumab (Tysabri)FDA Link
04/2022 - 09/2010
16InterferonsIBA
02/2021 - 10/2002
15Fingolimod Hydrochloride (FTY720)FDA Link
01/2021 - 09/2006
12Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2006
12AntibodiesIBA
01/2020 - 07/2003
10Oligoclonal BandsIBA
11/2022 - 05/2013
10ChitinasesIBA
11/2021 - 04/2010
9Immunoglobulin G (IgG)IBA
11/2022 - 12/2002
9ocrelizumabIBA
10/2021 - 01/2017
8CladribineFDA LinkGeneric
01/2022 - 09/2018
8Pharmaceutical PreparationsIBA
01/2020 - 08/2006
6TabletsIBA
01/2022 - 09/2018
6CytokinesIBA
01/2021 - 08/2010
6Therapeutic UsesIBA
01/2021 - 05/2008
6Myelin-Oligodendrocyte GlycoproteinIBA
01/2020 - 01/2007
6Interferon beta-1aFDA Link
11/2019 - 09/2004
6GadoliniumIBA
11/2019 - 02/2003
5ofatumumabFDA Link
06/2022 - 01/2020
5laquinimodIBA
04/2022 - 03/2012
5Alemtuzumab (Campath)FDA Link
01/2022 - 07/2012
5teriflunomideIBA
01/2022 - 11/2016
5AntigensIBA
01/2021 - 02/2002
5Interferon beta-1b (Betaseron)FDA Link
11/2011 - 06/2004
4Immunoglobulin M (IgM)IBA
06/2022 - 12/2002
4Monoclonal AntibodiesIBA
01/2022 - 04/2010
4ozanimodIBA
06/2021 - 11/2019
4Daclizumab (Zenapax)FDA Link
10/2020 - 04/2010
4Biological ProductsIBA
10/2020 - 07/2015
4Semaphorins (Semaphorin)IBA
01/2017 - 03/2013
4AutoantigensIBA
12/2016 - 12/2002
3Sphingosine-1-Phosphate ReceptorsIBA
06/2021 - 03/2016
3InflammasomesIBA
01/2021 - 03/2015
3EnzymesIBA
07/2016 - 02/2010
3HLA-DRB1 Chains (HLA DRB1)IBA
12/2014 - 09/2006
3Glatiramer Acetate (Copaxone)FDA Link
07/2013 - 06/2005
3Immunologic Factors (Immunomodulators)IBA
01/2013 - 02/2012
2Immunoglobulins (Immunoglobulin)IBA
11/2022 - 10/2021
2IronIBA
01/2022 - 01/2022
2LigandsIBA
11/2021 - 04/2013
2Interleukin-18 (Interleukin 18)IBA
01/2021 - 03/2015
2InterleukinsIBA
01/2021 - 10/2017
2nitazoxanide (NTZ)FDA Link
01/2021 - 08/2017
2Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
10/2020 - 01/2019
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2020 - 07/2014
2Adenosine Triphosphate (ATP)IBA
01/2020 - 09/2015
2LipidsIBA
01/2020 - 03/2015
2LipopolysaccharidesIBA
01/2020 - 01/2017
2Mitochondrial DNA (mtDNA)IBA
10/2019 - 02/2008
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2019 - 01/2018
2LuciferasesIBA
01/2019 - 09/2015
2Dimethyl FumarateIBA
01/2019 - 11/2016
24-Aminopyridine (4 Aminopyridine)FDA Link
01/2018 - 01/2012
2AutoantibodiesIBA
01/2018 - 12/2002
2frovatriptan (Allegro)FDA Link
01/2017 - 08/2014
2siponimodIBA
09/2016 - 08/2013
2dipeptidaseIBA
01/2016 - 11/2014
2DNA VaccinesIBA
01/2016 - 06/2012
2PlasminogenIBA
01/2016 - 11/2014
2Messenger RNA (mRNA)IBA
12/2015 - 05/2013

Therapy/Procedure

46Therapeutics
06/2022 - 06/2003
4Cognitive Training
01/2022 - 09/2015
3Injections
01/2022 - 07/2020
3Immunotherapy
01/2022 - 09/2008
3Immunomodulation
01/2012 - 11/2011
2Treatment Delay
11/2020 - 07/2013
2Precision Medicine
01/2020 - 01/2016
2Plasma Exchange
01/2020 - 02/2003